Skip to main content
. 2019 Aug 12;9(20):5828–5838. doi: 10.7150/thno.34837

Figure 4.

Figure 4

The targeting ability of HepM-PLGA to HepG2 cells and other cancer cells. (A) CLSM images of HepG2 cells, BGC-823 cells, HeLa cells and MCF-7 cells incubated with FITC-HepM-PLGA nanoparticles. (B) Quantitative histogram of the fluorescence intensities for the images in (A). Scale bar: 75 μm.